Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?

Crippa S, Partelli S, Zamboni G, Barugola G, Capelli P, Inama M, Bassi C, Pederzoli P, Falconi M.

Surgery. 2012 Sep;152(3 Suppl 1):S112-9. doi: 10.1016/j.surg.2012.05.017. Epub 2012 Jul 3.

PMID:
22766365
2.

[Surgery for pancreatic cancer].

Welsch T, Büchler MW, Schmidt J.

Z Gastroenterol. 2008 Dec;46(12):1393-403. doi: 10.1055/s-2008-1027790. Epub 2008 Dec 3. Review. German.

PMID:
19053009
3.

Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature.

Garcea G, Dennison AR, Pattenden CJ, Neal CP, Sutton CD, Berry DP.

JOP. 2008 Mar 8;9(2):99-132. Review.

4.

Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS).

Hartwig W, Vollmer CM, Fingerhut A, Yeo CJ, Neoptolemos JP, Adham M, Andrén-Sandberg A, Asbun HJ, Bassi C, Bockhorn M, Charnley R, Conlon KC, Dervenis C, Fernandez-Cruz L, Friess H, Gouma DJ, Imrie CW, Lillemoe KD, Milićević MN, Montorsi M, Shrikhande SV, Vashist YK, Izbicki JR, Büchler MW; International Study Group on Pancreatic Surgery.

Surgery. 2014 Jul;156(1):1-14. doi: 10.1016/j.surg.2014.02.009. Epub 2014 Feb 20.

PMID:
24856668
5.

Borderline resectable pancreatic cancer.

Hackert T, Ulrich A, Büchler MW.

Cancer Lett. 2016 Jun 1;375(2):231-7. doi: 10.1016/j.canlet.2016.02.039. Epub 2016 Mar 9. Review.

PMID:
26970276
6.

[New aspects of surgery for pancreatic cancer. Principles, results and evidence].

Distler M, Grützmann R.

Pathologe. 2012 Nov;33 Suppl 2:258-65. doi: 10.1007/s00292-012-1639-z. Review. German.

PMID:
23108784
7.

New challenges in perioperative management of pancreatic cancer.

Puleo F, Maréchal R, Demetter P, Bali MA, Calomme A, Closset J, Bachet JB, Deviere J, Van Laethem JL.

World J Gastroenterol. 2015 Feb 28;21(8):2281-93. doi: 10.3748/wjg.v21.i8.2281. Review.

8.

Selection criteria in resectable pancreatic cancer: a biological and morphological approach.

Tamburrino D, Partelli S, Crippa S, Manzoni A, Maurizi A, Falconi M.

World J Gastroenterol. 2014 Aug 28;20(32):11210-5. doi: 10.3748/wjg.v20.i32.11210. Review.

9.

Resection margins in pancreatic cancer.

Verbeke CS.

Surg Clin North Am. 2013 Jun;93(3):647-62. doi: 10.1016/j.suc.2013.02.008. Epub 2013 Mar 29. Review.

PMID:
23632150
10.

Update on the management of pancreatic cancer: surgery is not enough.

Ansari D, Gustafsson A, Andersson R.

World J Gastroenterol. 2015 Mar 21;21(11):3157-65. doi: 10.3748/wjg.v21.i11.3157. Review.

11.

Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.

Kang CM, Hwang HK, Choi SH, Lee WJ.

Surg Oncol. 2013 Jun;22(2):123-31. doi: 10.1016/j.suronc.2013.02.007. Epub 2013 Mar 19. Review.

PMID:
23518243
12.

[Pancreatic cancer in the elderly: guidelines and individualized therapy].

Nieß H, Kleespies A, Andrassy J, Pratschke S, Angele MK, Guba M, Jauch KW, Bruns CJ.

Chirurg. 2013 Apr;84(4):291-5. doi: 10.1007/s00104-012-2455-y. Review. German. Erratum in: Chirurg. 2013 Jun;84(6):522. Pratschke, P [corrected to Pratschke, S].

PMID:
23479275
13.

Pancreatic cancer: from bench to 5-year survival.

Kleeff J, Michalski C, Friess H, Büchler MW.

Pancreas. 2006 Aug;33(2):111-8. Review.

PMID:
16868475
14.

Surgical management of pancreatic cancer--pancreaticoduodenectomy.

Donahue TR, Reber HA.

Semin Oncol. 2015 Feb;42(1):98-109. doi: 10.1053/j.seminoncol.2014.12.009. Epub 2014 Dec 9. Review.

PMID:
25726055
15.

Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).

Bockhorn M, Uzunoglu FG, Adham M, Imrie C, Milicevic M, Sandberg AA, Asbun HJ, Bassi C, Büchler M, Charnley RM, Conlon K, Cruz LF, Dervenis C, Fingerhutt A, Friess H, Gouma DJ, Hartwig W, Lillemoe KD, Montorsi M, Neoptolemos JP, Shrikhande SV, Takaori K, Traverso W, Vashist YK, Vollmer C, Yeo CJ, Izbicki JR; International Study Group of Pancreatic Surgery.

Surgery. 2014 Jun;155(6):977-88. doi: 10.1016/j.surg.2014.02.001. Epub 2014 Feb 7.

PMID:
24856119
16.

The role of radiotherapy in multimodal treatment of pancreatic carcinoma.

Brunner TB, Scott-Brown M.

Radiat Oncol. 2010 Jul 8;5:64. doi: 10.1186/1748-717X-5-64. Review.

17.

Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).

Tol JA, Gouma DJ, Bassi C, Dervenis C, Montorsi M, Adham M, Andrén-Sandberg A, Asbun HJ, Bockhorn M, Büchler MW, Conlon KC, Fernández-Cruz L, Fingerhut A, Friess H, Hartwig W, Izbicki JR, Lillemoe KD, Milicevic MN, Neoptolemos JP, Shrikhande SV, Vollmer CM, Yeo CJ, Charnley RM; International Study Group on Pancreatic Surgery.

Surgery. 2014 Sep;156(3):591-600. doi: 10.1016/j.surg.2014.06.016. Epub 2014 Jul 22.

PMID:
25061003
18.

Neoadjuvant strategy as initial treatment in resectable pancreatic cancer: concrete evidence of benefit.

DE Felice F, Musio D, Raffetto N, Tombolini V.

Anticancer Res. 2014 Sep;34(9):4673-6. Review.

PMID:
25202043
19.

Strategies to improve the outcome in locally advanced pancreatic cancer.

Späth C, Nitsche U, Müller T, Michalski C, Erkan M, Kong B, Kleeff J.

Minerva Chir. 2015 Apr;70(2):97-106. Epub 2015 Feb 6. Review.

PMID:
25658301
20.

[Pancreatic cancer- a curable disease].

Limani P, Samaras P, Lesurtel M, Graf R, DeOliveira ML, Petrowsky H, Clavien PA.

Praxis (Bern 1994). 2015 Apr 22;104(9):453-60. doi: 10.1024/1661-8157/a001990. Review. German.

PMID:
25900693
Items per page

Supplemental Content

Write to the Help Desk